AstraZeneca and Medicaid Cancer Foundation (MCF) launch the Project Icon Nigeria initiative
Most prostate cancers are diagnosed at a late stage of the disease, which limits treatment options and has a major impact on the life expectancy of patients. To mark Prostate Cancer Awareness Month this September, AstraZeneca and Medicaid Cancer Foundation (MCF) launched the Project Icon Nigeria initiative, in collaboration with the Ministry of Health. The initiative will raise awareness of early warning signs, and support screening efforts.
Arpit Bansal, AstraZeneca Country Director for Sub Saharan Africa, said: “There is no doubt that urgent progress in cancer is sorely needed. Prostate cancer remains the most common form of cancer in men worldwide, despite an increase in the number of available therapies. At AstraZeneca, we are looking at ways to keep driving forward progress in cancer care and are dedicated to helping improve the outcomes of men affected by prostate cancer. Now, more than ever, we must advocate for earlier detection and diagnosis. Project Icon is part of this commitment. With awareness, early detection and prompt action and care, we can rewrite the story of prostate cancer in Nigeria.”
Read more here: https://qr.short.az/ProjectIconNigeria
